Media & Investors


« Back

Sunil Agarwal, M.D.

Dr. Agarwal is currently Senior Vice President and Chief Medical Officer at Ultragenyx where he is responsible for leading the company’s clinical development. Prior to Ultragenyx, Dr. Agarwal served in various leadership capacities at Genentech for 11 years. Most recently he held the position of Senior Vice President and Global Head of Clinical Development for OMNI (Ophthalmology, Metabolism, Neurosciences, Immunology and Infectious Diseases), and was involved in the development oversight of multiple molecules including RITUXAN®, ACTEMRA®, XOLAIR ®, LUCENTIS®, lebrikizumab, and ocrelizumab. Before joining Genentech, Dr. Agarwal was at MedImmune and Guilford Pharmaceuticals where he worked in both development and medical affairs. Dr. Agarwal obtained his B.S. in Neuro-Biology at Cornell University and then earned his M.D. from Tufts University School of Medicine.